Steward Partners Investment Advisory, LLC Concert Pharmaceuticals, Inc. Transaction History

Steward Partners Investment Advisory, LLC

$10.6 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 15, 2023	SELL	$4.34 - $5.84 $4,340 - $5,840	-1,000 Reduced 50.81%	968 $5,000
Q1 2022 May 02, 2022	SELL	$2.73 - $3.94 $10,944 - $15,795	-4,009 Reduced 67.07%	1,968 $7,000
Q4 2021 Feb 08, 2022	SELL	$2.69 - $4.22 $20,242 - $31,755	-7,525 Reduced 55.73%	5,977 $19,000
Q3 2021 Nov 12, 2021	SELL	$3.17 - $4.15 $7,978 - $10,445	-2,517 Reduced 15.71%	13,502 $44,000
Q2 2021 Aug 13, 2021	SELL	$3.77 - $5.24 $1.53 Million - $2.12 Million	-404,935 Reduced 96.19%	16,019 $68,000
Q1 2021 May 14, 2021	BUY	$4.86 - $13.07 $1.68 Million - $4.52 Million	345,943 Added 461.19%	420,954 $2.1 Million
Q4 2020 Feb 11, 2021	SELL	$9.48 - $12.84 $20,903 - $28,312	-2,205 Reduced 2.86%	75,011 $948,000
Q3 2020 Oct 30, 2020	SELL	$8.67 - $10.82 $10,551 - $13,167	-1,217 Reduced 1.55%	77,216 $758,000
Q2 2020 Aug 06, 2020	BUY	$7.8 - $11.52 $48,087 - $71,020	6,165 Added 8.53%	78,433 $780,000
Q1 2020 Apr 29, 2020	SELL	$5.98 - $13.09 $30,587 - $66,955	-5,115 Reduced 6.61%	72,268 $638,000
Q4 2019 Jan 17, 2020	BUY	$5.71 - $9.22 $45,314 - $73,169	7,936 Added 11.43%	77,383 $713,000
Q3 2019 Oct 30, 2019	BUY	$5.88 - $12.35 $19,433 - $40,816	3,305 Added 5.0%	69,447 $408,000
Q2 2019 Jul 25, 2019	BUY	$9.44 - $13.12 $48,210 - $67,003	5,107 Added 8.37%	66,142 $793,000
Q1 2019 Apr 30, 2019	BUY	$12.07 - $17.54 $28,364 - $41,219	2,350 Added 4.0%	61,035 $736,000
Q4 2018 Jan 15, 2019	BUY	$11.25 - $16.17 $120,656 - $173,423	10,725 Added 22.36%	58,685 $736,000
Q3 2018 Oct 23, 2018	BUY	$12.82 - $17.88 $60,254 - $84,036	4,700 Added 10.86%	47,960 $712,000
Q2 2018 Jul 20, 2018	BUY	$16.83 - $21.66 $223,165 - $287,211	13,260 Added 44.2%	43,260 $728,000
Q1 2018 Apr 20, 2018	BUY	$19.24 - $28.03 $276,094 - $402,230	14,350 Added 91.69%	30,000 $687,000
Q4 2017 Jan 19, 2018	BUY	$13.96 - $29.05 $148,674 - $309,382	10,650 Added 213.0%	15,650 $404,000
Q3 2017 Nov 22, 2017	BUY	$13.91 - $15.31 $35,470 - $39,040	2,550 Added 104.08%	5,000 $73,000
Q1 2017 Nov 22, 2017	BUY	N/A	2,450	2,450 $41,000

Others Institutions Holding CNCE

# of Institutions

Shares Held

Call Options Held

Put Options Held

Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

View Full List

About CONCERT PHARMACEUTICALS, INC.

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

More about CNCE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Steward Partners Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Steward Partners Investment Advisory, LLC with notifications on news.

Account